Verify that the dose range covers your target injection volume and that the increment size provides adequate precision for your protocol
Yet, that is what happens when a person with symptomatic B12 deficiency experiences that she or he needs more frequent supplementation than once every 3 months
We then monitor IGF-1 levels at regular intervals typically at 6 weeks, 3 months, and every 36 months thereafter to confirm the protocol is working and adjust dosing as needed
The most likely timeline points to a potential FDA approval in late the next year, with commercial availability following shortly after
However, discontinuation rates are similar for both treatments (approximately 6%), suggesting that while CagriSema causes more frequent gastrointestinal symptoms, they are generally manageable
BPC-157 reconstitution typically uses 12 mL of bacteriostatic water per 5 mg vial, producing a concentration of 2.55 mg/mL